Edition:
United Kingdom

Abbott Reports First Quarter GAAP Earnings Per Share Of $0.38 From Continuing Operations


Wednesday, 17 Apr 2019 

April 17 (Reuters) - Abbott Laboratories ::ABBOTT REPORTS FIRST-QUARTER 2019 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.63 FROM CONTINUING OPERATIONS.Q1 GAAP EARNINGS PER SHARE $0.38 FROM CONTINUING OPERATIONS.Q1 EARNINGS PER SHARE ESTIMATE $0.61 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.15 TO $3.25 FROM CONTINUING OPERATIONS.SEES Q2 ADJUSTED EARNINGS PER SHARE $0.79 TO $0.81 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES Q2 2019 GAAP EARNINGS PER SHARE $0.47 TO $0.49 FROM CONTINUING OPERATIONS.SEES FY 2019 GAAP EARNINGS PER SHARE $1.95 TO $2.05 FROM CONTINUING OPERATIONS.QTRLY TOTAL PEDIATRIC SALES $1,029 MILLION VERSUS $994 MILLION REPORTED LAST YEAR.FIRST-QUARTER WORLDWIDE SALES OF $7.5 BILLION INCREASED 2.0 PERCENT ON A REPORTED BASIS AND 7.1 PERCENT ON AN ORGANIC BASIS.PROJECTS STRONG FULL-YEAR OUTLOOK.QTRLY TOTAL NUTRITION SALES $1,792 MILLION VERSUS $1,756 MILLION REPORTED LAST YEAR.QTRLY TOTAL DIAGNOSTICS SALES $1,841 MILLION VERSUS $1,837 MILLION REPORTED LAST YEAR.ABBOTT FORECASTS SPECIFIED ITEMS FOR Q2 2019 OF $0.32 PER SHARE.SAYS "WE'RE RIGHT ON TRACK WITH OUR EXPECTATIONS TO START THE YEAR".ABBOTT FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2019 OF $1.20 PER SHARE.BOARD OF DIRECTORS OF ABBOTT DECLARED COMPANY'S QUARTERLY DIVIDEND OF $0.32 PER SHARE.SAYS "WE'RE TARGETING ANOTHER YEAR OF STRONG SALES AND EARNINGS GROWTH".Q1 REVENUE VIEW $7.47 BILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE VIEW $0.80 -- REFINITIV IBES DATA.